Roundtable discussion. Maximizing potential cost benefits of teicoplanin through appropriate usage.
School of Medicine, Wayne State University, Detroit, MI.
M J
MJ
Rybak
R
R
Allen
P
P
Arnow
P C
PC
Craven
R
R
Freeman
R N
RN
Grüneberg
J
J
Korin
C H
CH
Nightingale
E
E
Rubinstein
G S
GS
Schaison
D003363:Cost Control; D003428:Cross Infection; D016527:Drug Costs; D005572:Formularies, Hospital as Topic; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D007349:Insurance, Health, Reimbursement; D016365:Liability, Legal; D017334:Teicoplanin / Q000008:administration & dosage / Q000191:economics*